insights_auto
Why is EDIT down 2,41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,82 US$
arrow_downward
-2,41%(-0,045) 1D
1,92 US$
arrow_upward
+5,21% (+0,095)bedtimeAfter hours
Closed: 17 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
281,67 მლნ.
Avg. vol.
2,41 მლნ.
Volume
2,10 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
281,67 მლნ.
Avg. vol.
2,41 მლნ.
Volume
2,10 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
3 საათის წინ
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
TradingView
·
1 საათის წინ
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
ChartMill
·
3 საათის წინ
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
47 წუთის წინ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc